They were facing a full FDA trial for the whole thing. Certainly a perverse incentive not to fully develop the product :) Considering how poor the sales of the

They were facing a full FDA trial for the whole thing. Certainly a perverse incentive not to fully develop the product :) Considering how poor the sales of the tablet have been, I'm sure they'd rather be charging $20,000 per treatment. They actually sold the entire tablet business for $2m which is pretty abysmal compared to the value of 'curing tooth decay forever'